Literature DB >> 23242167

Inflammatory activation following interruption of long-term cardiac resynchronization therapy.

Andrzej Rubaj1, Piotr Ruciński, Krzysztof Oleszczak, Michał K Trojnar, Maciej Wójcik, Andrzej Wysokiński, Andrzej Kutarski.   

Abstract

Previous observations suggest that cardiac resynchronization therapy (CRT) may exert an anti-inflammatory effect. The objective of this study was to evaluate the effect of temporary interruption of long-term CRT on plasma concentrations of proinflammatory cytokines and brain natriuretic peptide (BNP). The study group consisted of 54 patients (32 male and 22 female, mean age 64 years) with chronic heart failure (HF) treated with CRT. BNP, high-sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6), and neopterin were measured three times: after 26-28 weeks of continuous CRT (CRT-on), 48 h after its cessation (CRT-off), and 48 h after switching the CRT-on again. CRT interruption resulted in a significant worsening of left ventricular systolic function: reduction of cardiac output (CO), dP/dt, and left ventricular ejection fraction (LVEF), as well as deterioration of mitral regurgitation in the CRT responder group. A significant increase in serum concentrations of hs-CRP, neopterin, IL-6, and BNP was noted in this subpopulation. In CRT nonresponders, no significant changes were observed. In responders the changes in serum concentrations of hs-CRP, IL-6, neopterin, and BNP, following CRT interruption, significantly correlated with the respective changes in thoracic fluid content (TFC) and inversely correlated with LVEF changes. Even short (48 h) interruption of long-term CRT led to a significant increase of proinflammatory cytokines and BNP concentrations in responders. The changes in hs-CRP, IL-6, neopterin, and BNP concentrations correlated with the change in TFC-marker of pulmonary congestion and inversely correlated with the change in LVEF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242167     DOI: 10.1007/s00380-012-0285-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

Review 1.  Novel therapies for heart failure: focus on anti-inflammatory strategies.

Authors:  Kumudha Ramasubbu; Guilherme Oliveira; Guillermo Torre-Amione
Journal:  Congest Heart Fail       Date:  2006 May-Jun

Review 2.  The technique of impedance cardiography.

Authors:  H H Woltjer; H J Bogaard; P M de Vries
Journal:  Eur Heart J       Date:  1997-09       Impact factor: 29.983

3.  Prognostic value of serum cytokines in patients with congestive heart failure.

Authors:  J Orús; E Roig; F Perez-Villa; C Paré; M Azqueta; X Filella; M Heras; G Sanz
Journal:  J Heart Lung Transplant       Date:  2000-05       Impact factor: 10.247

4.  Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome.

Authors:  Babak Nazer; Kausik K Ray; Sarah Sloan; Benjamin Scirica; David A Morrow; Christopher P Cannon; Eugene Braunwald
Journal:  Eur Heart J       Date:  2011-02-22       Impact factor: 29.983

5.  Anti-inflammatory effect of cardiac resynchronization therapy.

Authors:  Knut T Lappegård; Hanne Bjørnstad
Journal:  Pacing Clin Electrophysiol       Date:  2006-07       Impact factor: 1.976

6.  Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure.

Authors:  P Ferdinandy; H Danial; I Ambrus; R A Rothery; R Schulz
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

7.  Inflammatory mediators in Chinese patients with congestive heart failure.

Authors:  Yongqing Wang; Yanli Zhou; Ling Meng; Xinzheng Lu; Ning Ou; Xinli Li
Journal:  J Clin Pharmacol       Date:  2009-05       Impact factor: 3.126

8.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

9.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

Review 10.  The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials.

Authors:  Andrea Rossi; Giuseppe Rossi; Marcello Piacenti; Umberto Startari; Luca Panchetti; Maria-Aurora Morales
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

View more
  7 in total

1.  Unusual "ratchet syndrome": spontaneous lead retraction after a generator exchange.

Authors:  Koichiro Ejima; Morio Shoda; Bun Yashiro; Kentaro Yoshida; Toshiaki Nuki; Ken Kato; Tetsuyuki Manaka; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2013-07-12       Impact factor: 2.037

Review 2.  Recent advances in the optimization of cardiac resynchronization therapy.

Authors:  Satish Chandraprakasam; Gina G Mentzer
Journal:  Curr Heart Fail Rep       Date:  2015-02

3.  Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure.

Authors:  Zhili Shao; Renliang Zhang; Kevin Shrestha; Allen G Borowski; Andres Schuster; Akanksha Thakur; Stanley L Hazen; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2014-03-18       Impact factor: 2.778

4.  Pentraxin 3 is a local inflammatory marker in atrial fibrillation.

Authors:  Takeshi Soeki; Sachiko Bando; Etsuko Uematsu; Tomomi Matsuura; Toshiyuki Niki; Takayuki Ise; Kenya Kusunose; Junko Hotchi; Yuka Ueda; Noriko Tomita; Koji Yamaguchi; Shusuke Yagi; Daiju Fukuda; Yoshio Taketani; Takashi Iwase; Hirotsugu Yamada; Tetsuzo Wakatsuki; Michio Shimabukuro; Masataka Sata
Journal:  Heart Vessels       Date:  2013-08-27       Impact factor: 2.037

5.  Successful dual chamber ICD implantation via a persistent left superior vena cava after ratchet syndrome.

Authors:  Naofumi Anjo; Shiro Nakahara; Tohru Kamijima; Yuichi Hori; Ayako Nakagawa; Naoki Nishiyama; Kouta Yamada; Takaaki Komatsu; Sayuki Kobayashi; Yoshihiko Sakai; Isao Taguchi
Journal:  J Arrhythm       Date:  2016-02-06

6.  Assessing long-term survival and hospitalization following transvenous lead extraction in patients with cardiac resynchronization therapy devices: A propensity score-matched analysis.

Authors:  Vishal S Mehta; Hugh O'Brien; Mark K Elliott; Baldeep S Sidhu; Justin Gould; Anoop K Shetty; Steven Niederer; Christopher A Rinaldi
Journal:  Heart Rhythm O2       Date:  2021-10-30

7.  Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy.

Authors:  Katarzyna Ptaszynska-Kopczynska; Anna Szpakowicz; Marta Marcinkiewicz-Siemion; Anna Lisowska; Ewa Waszkiewicz; Marcin Witkowski; Piotr Jakim; Bogdan Galar; Wlodzimierz J Musial; Karol A Kamiński
Journal:  Arch Med Sci       Date:  2016-03-17       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.